Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COBRA PzF Stent OCT Evaluation vs DES
NCT02224235Terminated
- Sponsor
- CeloNova BioSciences, Inc.
- Start
- Jun 2014
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
Randomised, open-label trial in stable angina (3 arms), sponsored by CeloNova BioSciences, Inc. Primary endpoints: Neointimal coverage of the stent as measured using OCT at 3 months, Presence of thrombus formation as measured by OCT at 3 months and 7 more. Started Jun 2014; status: terminated.
02
Conditions
stable angina
Beyond the preview
Go deeper on NCT02224235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02224235.